Eleni Kampylafka

Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study

Elizabeth Araújo, Matthias Englbrecht, Sabrina Hoepken et al. · Seminars in Arthritis and Rheumatism · 2018 · 130 citations

Life Sciences, Immunology, Internal Medicine +13

Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients

Eleni Kampylafka, Michalis L. Kosmidis, Demosthenes B. Panagiotakos et al. · PLoS ONE · 2013 · 119 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13

Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation—data from the prospective IVEPSA study

Eleni Kampylafka, David Simón, Isabelle d’Oliveira et al. · Arthritis Research & Therapy · 2019 · 104 citations · Full text

Medicine, Dermatology, Immunology +17

Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study

Eleni Kampylafka, Isabelle d’Oliveira, Christina Linz et al. · Arthritis Research & Therapy · 2018 · 83 citations · Full text

Medicine, Immunology, Bone Metabolism +16

Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial

Johannes Knitza, Jacob Mohn, Christina Bergmann et al. · Arthritis Research & Therapy · 2021 · 73 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17